Sign inJoin waitlistJoin the waitlist

Robert Schilz

Director, Pulmonary Vascular Disease Program · UH Cleveland Medical Center

Credentials: · · · · ·

History

Pulmonary Vascular Disease Program · UH Cleveland Medical Center
Present
CWRU School of Medicine
Present

Yale University School Of Medicine
1993–1996
1992–1993
Yale University
Cleveland Clinic
1989–1992
Sparrow Hospital
1988–1989
Michigan State University College Of Human Medicine
1988
University Of Wisconsin-Madison
1979

Research

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial
Annals of Internal Medicine · 2000 · 798 citations
The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants
Transplant Infectious Disease · 2002 · 249 citations
A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough
The American Journal of Gastroenterology · 1999 · 197 citations

Raymond Onders
8 papers
Atul Mehta
6 papers
Jun Li
6 papers
Mehdi Shishehbor
6 papers
RO
Ronald Oudiz
6 papers
Tarek Hammad
6 papers · 3 as a fellow
VM
Vallerie Mclaughlin
6 papers
Bashar Katirji
5 papers
Teresa Carman
5 papers
AF
Adaani Frost
4 papers
Ivan Robbins
4 papers
Jane Little
4 papers

Clinical trials

S-Nitrosylation Therapy of COVID-19
Principal investigator · Withdrawn · Early phase 1
James Reynolds
2021–2025